This finding provides novel information on the ability to detect intracellular RNA from IPMN patients and suggests that GAS5 may serve as a secondary diagnostic marker for the identification and pathological classification of IPMN. Here, GAS5 is linked to pancreatic intraductal papillary-mucinous neoplasm.